Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery
NCT03639896 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 464
Last updated 2021-02-10
Summary
The incidence of postoperative cognitive injury is high in elderly patients, especially after major surgery. The relevant pathophysiological mechanisms are still unclear, and the possible mechanisms that have been proposed so far include inflammation, neurotransmitter imbalance and metabolic disorders. In recent years, clinical studies of acute brain dysfunction after vascular endothelial injury have attracted attention.
Degradation of the endothelial glycocalyx layer and subsequent shedding of its constituents is seen as an early marker of endothelial injury, and may increase vascular permeability.Many preclinical and clinical studies have demonstrated an association between inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-10 and glycocalyx degradation biomarkers.
The scholars found evidence of plasma endothelial injury after abdominal open surgery in the elderly. Dexmedetomidine could attenuate stress response such as TNF-α, IL-1β and IL-6. Based on the above evidence, we hypothesize that elderly patients experience inflammatory response secondary to surgical traumatic stress after major surgery, greatly increasing the degree of endothelial injury (heparan sulphate and syndecan-1), reducing brain perfusion while increasing Blood-brain barrier permeability (S100B level), promoting the release of cytokines Interleukin-2(IL-2), Interleukin-6(IL-6), tumor necrosis factor-alpha(TNF-α) ,and vascular endothelial growth factor (VEGF) while reducing brain-derived neurotrophic factor(BDNF) synthesis, then leading to postoperative acute spasm. We would test the hypothesis that can reverse these effects and improve cognitive deficits.
Conditions
- Endothelial Dysfunction
- Blood Brain Barrier Defect
- Postoperative Cognitive Dysfunction
Interventions
- DRUG
-
Dexmedetomidine
0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
- DRUG
-
Saline
0.5μg/kg saline as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
Sponsors & Collaborators
-
Hangzhou Cancer Hospital
collaborator OTHER -
The First Affiliated Hospital of Anhui Medical University
lead OTHER
Principal Investigators
-
Xinqi Cheng, PhD · The First Affiliated Hospital of Anhui Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-01
- Primary Completion
- 2020-10-30
- Completion
- 2020-10-31
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Blood Biomarkers as an Indicator of Delayed Neurocognitive Recovery
NCT04679259 ·Status: COMPLETED ·Phase: NA
-
Peri-Anesthetic Imaging of Cognitive Dysfunction
NCT01322672 ·Status: COMPLETED
-
The Reliability and Validity of Perioperative Cognitive Test Network Platform for Monitoring Neurocognitive Changes
NCT06028568 ·Status: UNKNOWN
-
Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment
NCT07135336 ·Status: RECRUITING
-
Clinical Outcomes in Elderly Patients With Preoperative Cognitive Dysfunction
NCT03143595 ·Status: UNKNOWN
-
Study of Postoperative Cognitive Decline in Aged Patients
NCT03765840 ·Status: UNKNOWN
-
A Predictive Study of Peripheral Blood Biomarkers on Postoperative Neurocognitive Dysfunction in Elderly Frail and Non-frail Patients Undergoing Gastrointestinal Surgery
NCT06334289 ·Status: NOT_YET_RECRUITING
-
The Neuroprotective Effect of Dexmedetomidine Preserving Brain Functional Connectivity in Elderly Patients
NCT04973124 ·Status: COMPLETED ·Phase: NA
-
A Prospective Cohort Study of Perioperative Covert Stroke and Postoperative Cognitive Dysfunction
NCT03081429 ·Status: COMPLETED
-
Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders
NCT04566562 ·Status: COMPLETED
-
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery
NCT02123355 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Ketogenic Diet to Improve Post Operative Cognitive Decline in Cardiac Surgery
NCT06480708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neuroimaging Combining Biomarkers for Identifying Long-term Cognitive Dysfunction and Delirium
NCT05594966 ·Status: UNKNOWN
-
Prediction Model of Long-term Cognitive Dysfunction and Delirium After Cardiac Surgery
NCT05972057 ·Status: UNKNOWN
-
Correlation Between Blood Biomarkers and Postoperative Delirium in Elective Non-Cardiac Surgery.
NCT03915314 ·Status: UNKNOWN
-
Biomarkers and Risk Factors for Perioperative Neurocognitive Dysfunction in Elderly Patients
NCT06044207 ·Status: RECRUITING
-
MD2, Cystatin C and DNA Methylation Tags as Serum Biomarkers for POCD.
NCT03610191 ·Status: UNKNOWN
-
Effect of Dexmedetomidine on Postoperative Delirium Inflammasome Activation Inhibition
NCT03588988 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Perioperative Systemic Inflammation in the Development of PND in Cirrhotic Patients
NCT07082946 ·Status: NOT_YET_RECRUITING
-
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
NCT00455143 ·Status: TERMINATED ·Phase: PHASE4
-
Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids
NCT00850928 ·Status: COMPLETED
-
Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery
NCT03480061 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients
NCT05555693 ·Status: RECRUITING
-
Relationship Between Perioperative Carotid Blood Flow Monitoring and Cerebral Function Protection in Cardiac Surgery
NCT05586347 ·Status: COMPLETED ·Phase: NA
-
The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.
NCT03324867 ·Status: UNKNOWN ·Phase: NA